ConductScience.org, home

Paper31377342

Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.

Patil SU and 8 others. J Allergy Clin Immunol, 2019. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy. Papers, record 31377342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31377342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
PubMed
Journal
J Allergy Clin Immunol
PubMed
Year
2019
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.62
iCite
Revised in PubMed
2020-11-02
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Patil SUSarita U
2Steinbrecher JJohanna
3Calatroni AAgustin
4Smith NNeal
5Ma AAlex
6Ruiter BBert
7Virkud YYamini
8Schneider MMichael
9Shreffler WGWayne G

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
2S Albumins, PlantMajor topic
Antigens, PlantMajor topic
Basophil Degranulation TestMajor topic
BasophilsMajor topic
Desensitization, ImmunologicMajor topic
Peanut HypersensitivityMajor topic
Administration, Oral
Adolescent
Arachis
Child
Female
Humans
Immunoglobulin E
Male
Prognosis
Treatment Outcome

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
L40 AI120059NIAID NIH HHSUnited StatesL40AI120059PubMed and NIHNIH RePORTER
S10 RR020936NCRR NIH HHSUnited StatesS10RR020936PubMedNIH RePORTER
S10 OD012027NIH HHSUnited StatesS10OD012027PubMedNIH RePORTER
K23 AI121491NIAID NIH HHSUnited StatesK23AI121491PubMed and NIHNIH RePORTER
S10 RR023440NCRR NIH HHSUnited StatesS10RR023440PubMedNIH RePORTER
K23 AI130408NIAID NIH HHSUnited StatesK23AI130408PubMedNIH RePORTER
UL1 TR000170NCATS NIH HHSUnited StatesUL1TR000170PubMedNIH RePORTER
UL1 TR001102NCATS NIH HHSUnited StatesUL1TR001102PubMedNIH RePORTER
UL1 RR025758NCRR NIH HHSUnited StatesUL1RR025758PubMedNIH RePORTER
S10 OD016372NIH HHSUnited StatesS10OD016372PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in31589878Blocking antibodies in immunotherapy: Quality versus quantity.https://conductscience.org/library/papers/31589878

Source PubMed

Download CSV of comments and corrections

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125670011IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.J Allergy Clin Immunol2015https://conductscience.org/library/papers/25670011PubMed
227015954Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.Allergy2016https://conductscience.org/library/papers/27015954PubMed
322385632Increasing the accuracy of peanut allergy diagnosis by using Ara h 2.J Allergy Clin Immunol2012https://conductscience.org/library/papers/22385632PubMed
422702505Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization.Clin Exp Allergy2012https://conductscience.org/library/papers/22702505PubMed
521377034A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.J Allergy Clin Immunol2011https://conductscience.org/library/papers/21377034PubMed
628618090Road map for the clinical application of the basophil activation test in food allergy.Clin Exp Allergy2017https://conductscience.org/library/papers/28618090PubMed
718572230Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.J Allergy Clin Immunol2008https://conductscience.org/library/papers/18572230PubMed
825567046Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.J Allergy Clin Immunol2015https://conductscience.org/library/papers/25567046PubMed
920462634US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up.J Allergy Clin Immunol2010https://conductscience.org/library/papers/20462634PubMed
1022132885Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.Clin Exp Immunol2012https://conductscience.org/library/papers/22132885PubMed
1121281959Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.J Allergy Clin Immunol2011https://conductscience.org/library/papers/21281959PubMed
1222077562Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy.Allergy2012https://conductscience.org/library/papers/22077562PubMed
1322805467Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.Clin Exp Allergy2012https://conductscience.org/library/papers/22805467PubMed
1425042981Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.J Allergy Clin Immunol2014https://conductscience.org/library/papers/25042981PubMed
1526774660Parameters determining the efficacy of CD32 to inhibit activation of FcεRI in human basophils.J Allergy Clin Immunol2016https://conductscience.org/library/papers/26774660PubMed
1625065721Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children.J Allergy Clin Immunol2014https://conductscience.org/library/papers/25065721PubMed
1716096348ROCR: visualizing classifier performance in R.Bioinformatics2005https://conductscience.org/library/papers/16096348PubMed
1826198455The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.Allergy2015https://conductscience.org/library/papers/26198455PubMed
1929288078Immune mechanisms of oral immunotherapy.J Allergy Clin Immunol2018https://conductscience.org/library/papers/29288078PubMed
2025542883Suppression of the immunologic response to peanut during immunotherapy is often transient.J Allergy Clin Immunol2015https://conductscience.org/library/papers/25542883PubMed

See all 31 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
42094701Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy.J Inflamm Res2026https://conductscience.org/library/papers/42094701PubMed
41913645Predictive Biomarkers for Sustained Unresponsiveness Following Oral Immunotherapy.Clin Exp Allergy2026https://conductscience.org/library/papers/41913645PubMed
41660622Emerging diagnostic and therapeutic opportunities in food allergy.Front Immunol2025https://conductscience.org/library/papers/41660622PubMed
41225120Modulating the Allergen-Specific Immune Response to Achieve Remission of Food Allergy Through Oral Immunotherapy.Adv Exp Med Biol2026https://conductscience.org/library/papers/41225120PubMed
40558527Advances in Food Allergy Immunotherapy: Current Strategies and Role of Antibodies Isotypes.Cells2025https://conductscience.org/library/papers/40558527PubMed
40542457Epitope-Specific Antibodies in Allergic Disease and Clinical Tolerance.Immunol Rev2025https://conductscience.org/library/papers/40542457PubMed
40498852Germline-encoded recognition of peanut underlies development of convergent antibodies in humans.Sci Transl Med2025https://conductscience.org/library/papers/40498852PubMed
40245952Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy.J Allergy Clin Immunol2025https://conductscience.org/library/papers/40245952PubMed
40154576Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.J Allergy Clin Immunol2025https://conductscience.org/library/papers/40154576PubMed
39530396Immunomodulatory metabolites in IgE-mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling.Pediatr Allergy Immunol2024https://conductscience.org/library/papers/39530396PubMed
39041740Whence and wherefore IgE?Immunol Rev2024https://conductscience.org/library/papers/39041740PubMed
38460677Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy.J Allergy Clin Immunol2024https://conductscience.org/library/papers/38460677PubMed
38441821A Review of Shared Decision-Making, Published Protocols, and Post-desensitization Strategies in Oral Immunotherapy (OIT).Curr Allergy Asthma Rep2024https://conductscience.org/library/papers/38441821PubMed
38256382Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy.Medicina (Kaunas)2024https://conductscience.org/library/papers/38256382PubMed
38140391Peanut Allergy and Component-Resolved Diagnostics Possibilities-What Are the Benefits?Nutrients2023https://conductscience.org/library/papers/38140391PubMed
37849958Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand.Front Allergy2023https://conductscience.org/library/papers/37849958PubMed
37711220JAK1 inhibition with abrocitinib decreases allergen-specific basophil and T-cell activation in pediatric peanut allergy.J Allergy Clin Immunol Glob2023https://conductscience.org/library/papers/37711220PubMed
37350169Practical issues of oral immunotherapy for egg or milk allergy.Clin Exp Pediatr2024https://conductscience.org/library/papers/37350169PubMed
37241015Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation.J Pers Med2023https://conductscience.org/library/papers/37241015PubMed
36880703Targeting type 2 immunity and the future of food allergy treatment.J Exp Med2023https://conductscience.org/library/papers/36880703PubMed

See all 43 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCR31232PubTator's text mininghttps://conductscience.org/library/genes/1232NCBI Gene
CD63967PubTator's text mininghttps://conductscience.org/library/genes/967NCBI Gene
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31377342

GET https://conductscience.org/api/papers/v1/31377342/references?page=2